Feed aggregator

Breaking the Cycle of Inflammation in Parkinson’s Disease

Biospace news - Mon, 07/15/2024 - 02:00
Breaking the Cycle of Inflammation in Parkinson’s Disease 7/15/2024

5 Neuro Data Readouts to Watch in the Second Half of 2024

Biospace news - Mon, 07/15/2024 - 02:00
5 Neuro Data Readouts to Watch in the Second Half of 2024 7/15/2024

SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological

Biospace news - Mon, 07/15/2024 - 02:00
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological 7/15/2024

Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases

Biospace news - Mon, 07/15/2024 - 02:00
Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases 7/15/2024

Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data

Biospace news - Sat, 07/06/2024 - 02:00
Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data 6/7/2024

FDA Raises Concerns About Lilly’s Donanemab Alzheimer’s Candidate Ahead of Adcomm

Biospace news - Sat, 07/06/2024 - 02:00
FDA Raises Concerns About Lilly’s Donanemab Alzheimer’s Candidate Ahead of Adcomm 6/7/2024

FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder

Biospace news - Sat, 07/06/2024 - 02:00
FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder 6/7/2024

Biomea’s Stock Nosedives More Than 60% as FDA Puts Clinical Hold on Diabetes Candidate

Biospace news - Sat, 07/06/2024 - 02:00
Biomea’s Stock Nosedives More Than 60% as FDA Puts Clinical Hold on Diabetes Candidate 6/7/2024

MASH Clash Between Lilly and Boehringer-Zealand Takes Center Stage at EASL24

Biospace news - Sat, 07/06/2024 - 02:00
MASH Clash Between Lilly and Boehringer-Zealand Takes Center Stage at EASL24 6/7/2024